Document Detail


Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome.
MedLine Citation:
PMID:  7820407     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A retrospective review was performed to evaluate the effectiveness of radioiodine in the ablation of residual thyroid tissue after surgery for differentiated thyroid cancer. 121 patients were treated at the Princess Margaret Hospital, Toronto, Canada between 1977 and 1989, with the activity of radioiodine determined empirically. Ablation of residual thyroid was determined by 131I nuclear scans, using absent visible uptake (compared with background) as the criterion for successful ablation. 97 patients (80%) had successful ablation of residual thyroid tissue after the first administration of radioiodine. Patients with higher iodine uptake in the neck had a tendency to receive higher activities of 131I. There were no statistically significant differences in age, sex, type of surgery, initial iodine uptake in the neck and administered radioiodine activity between those successfully ablated and those that were not. Patients receiving less than 3.7 GBq (100 mCi) tended to have lower iodine uptake (< 5% at 24 or 48 h), but their rate of thyroid ablation was just as high as those given 3.7 GBq or more. In order to take advantage of this, we have formalized our approach by deriving guidelines to the empiric determination of radioiodine activity based on the iodine uptake in the neck. Among the 11 patients treated with lobectomy only, the ablation rate was 64%. Although this was not significantly lower than for other forms of surgery, we continue to recommend completion thyroidectomy for this group of patients, if the goal of treatment is to ablate all thyroid tissue.
Authors:
J P Logue; R W Tsang; J D Brierley; W J Simpson
Related Documents :
23919667 - A prospective, randomised study of a novel transforming methacrylate dressing compared ...
9854587 - Postoperative hypocalcemia in patients who did or did not undergo parathyroid autotrans...
11967907 - Significance of postoperative serum thyroglobulin levels in patients with papillary and...
6688767 - Outcome of patients with graves' disease after long-term medical treatment guided by tr...
17550987 - Evolution of different mri measures in patients with active relapsing-remitting multipl...
24807337 - Preemptive use of gabapentin in abdominal hysterectomy: a systematic review and meta-an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The British journal of radiology     Volume:  67     ISSN:  0007-1285     ISO Abbreviation:  Br J Radiol     Publication Date:  1994 Nov 
Date Detail:
Created Date:  1995-02-16     Completed Date:  1995-02-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0373125     Medline TA:  Br J Radiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1127-31     Citation Subset:  AIM; IM    
Affiliation:
Department of Radiation Oncology, University of Toronto, Ontario Cancer Institute/Princess Margaret Hospital, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Female
Humans
Iodine Radioisotopes / pharmacokinetics,  therapeutic use*
Male
Middle Aged
Neoplasm, Residual
Radiotherapy Dosage
Radiotherapy, Adjuvant
Retrospective Studies
Thyroid Neoplasms / metabolism,  radiotherapy*,  surgery
Thyroidectomy
Treatment Outcome
Chemical
Reg. No./Substance:
0/Iodine Radioisotopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Absorbed dose distribution measurements in brachytherapy using ferrous sulphate gel and magnetic res...
Next Document:  Case report: saccular aneurysm of the intraorbital ophthalmic artery.